Crohn Disease Clinical Trials

864 clinical trials for Crohn Disease across international registries, including 188 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• PIBD-SETQuality: the Inception Cohort and Safety Registry — RECRUITING
• Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission — RECRUITING · NA
• HB-adMSCs for the Treatment of Crohn's Disease — RECRUITING · PHASE2
• A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease — RECRUITING · PHASE2
• A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease — RECRUITING · PHASE2
• Low Dose IL-2 for the Treatment of Crohn's Disease — RECRUITING · PHASE1
• A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease — RECRUITING · PHASE3
• A Study of Guselkumab in Participants With Crohn's Disease and Ulcerative Colitis — RECRUITING
• A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease — RECRUITING · PHASE3
• A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease — RECRUITING · PHASE2
• A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease and Ulcerative Colitis — RECRUITING
• Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO — RECRUITING · PHASE1
• STUDY OF THE ADDED VALUE OF A TRANSMURAL EVALUATION IN PATIENTS WITH CROHN'S DISEASE UNDER BIOTHERAPY WITH CLOSE FECAL CALPROTECTIN FOLLOW-UP — RECRUITING · NA
• Concordance Between Inflammatory Activity Assessed by Enteric MRI With and Without Intestinal Distension Product in Patients With Ileal Crohn's Disease. — RECRUITING · NA
• Prospective Risk Evaluation and Detection of Crohn's Disease in First-degree Relatives — RECRUITING
• A Specific Probiotic in thE MOdulation of Gut Microbiota of patieNts With Mild-to-modErate Ulcerative Colitis — RECRUITING · NA
• Autologous Stem Cell Transplant for Crohn's Disease — RECRUITING · PHASE2
• Developing a Self-Management Intervention to Improve Health Outcomes for Patients With Inflammatory Bowel Disease — RECRUITING · NA
• Cranberry and Gut Health in Crohn's Disease — RECRUITING · PHASE1
• Evaluation of the Accuracy of Immunostaining of Claudin 2 to Detect Active or Inactive Inflammation in Endoscopic Biopsies of IBD — RECRUITING
• Assessment and Educational Intervention to Reduce Ultra-processed Food Consumption in Pediatric Patients With IBD — RECRUITING
• Open-label Single-arm Study to Assess the Efficacy of Mirikizumab in Patients With Inflammatory Strictures Due to CD — RECRUITING · PHASE4
• Fecal Microbiota Transplantation in Pediatric Crohn's Disease — RECRUITING · NA
• Comparison of the Efficacy of Different Biologic Agents in Preventing Postoperative Endoscopic Recurrence of Crohn's Disease — RECRUITING
• Fecal Microbiota Transplantation as the First-line Treatment in Active Pediatric Crohn's Disease — RECRUITING · NA
• Switching to the IL-23 Inhibitor Guselkumab for People With Active IBD Who Previously Used Ustekinumab (SHIFT-IBD) — RECRUITING
• Surgery vs Biologics for Treating Stricturing CD--a RCT — RECRUITING · NA
• NAZA - Nottingham/Astra ZenecA Prospective IBD Cohort Study — RECRUITING
• Improving Outcomes and Reducing Disparities for Patients With Inflammatory Bowel Disease Through Epidemiology and Enhanced Disease Management — RECRUITING · NA
• IBD Biomarker Discovery and Validation Platform — RECRUITING
• A Study to Evaluate the Efficacy of Guselkumab in Chinese Participants With Crohn's Disease (CD) — RECRUITING · PHASE4
• A Real-World Study of Guselkumab in Ulcerative Colitis and Crohn's Disease in Saudi Arabia — RECRUITING
• Optimal Care With Guselkumab in Crohn's Disease / OPTIM Study A Prospective Open Label Interventional, Multicenter Study — RECRUITING · PHASE4
• Partial Enteral Nutrition to Prevent Weight Loss and Sarcopenia in IBD Patients at Nutritional Risk - SIMBA — RECRUITING · NA
• Study on the Treatment of Anal Fistulas Using Alofisel Versus Fat Autologous Stem Cells — RECRUITING
• Gastro-intestinal Biopotential Recorder by Means of Surface ELEctrodes — RECRUITING · NA
• Standardized Microbiota Transplant Therapy in Crohn's Disease — RECRUITING · PHASE2
• Identification of Fecal Microbiota Biomarkers of Spondyloarthritis in Patients Suffering From Crohn's Disease. — RECRUITING · NA
• Regenerative Endoscopy in Refractory Perianal Crohn's Disease — RECRUITING · NA
• Intestinal Organoids — RECRUITING · NA
• Impact of Advanced Crohn's Disease Therapies on Sleep Quality — RECRUITING
• Individualizing Anti-TNF Therapy in Patients With Inflammatory Bowel Disease — RECRUITING
• A Study to Assess Real-world Outcomes for Long-Term Use of Guselkumab — RECRUITING
• Decoding the Clinical Impact of Host and Microbial Intestinal Proteomic Landscape in Crohn's Disease — RECRUITING
• TNFi Plus Low-Dose Upadacitinib vs TNFi Intensification in Crohn's Disease With Suboptimal Response — RECRUITING · PHASE4
• Evaluation of Therapeutic Strategy to Prevent Crohn's Disease Endoscopic poSToperatIve recurreNce Based on earlY Dosage of Faecal Calprotectin — RECRUITING · NA
• Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease — RECRUITING · PHASE2
• Tolerance of Local Administration of Cryopreserved Autologous Stromal Vascular Fraction Combined With Micrograft for the Treatment of Refractory Ano-perineal Fistulas in Crohn's Disease — RECRUITING · PHASE1
• Utility of Random Biopsies in Patients With Inflammatory Bowel Disease — RECRUITING · NA
• Leucine-rich α2-glycoprotein Correlation With Clinical, Endoscopic and Histological Disease Activity of IBD in a EuRopean Context — RECRUITING

Refine this search